D&O cover gap review in Ireland for cross-border groups

A D&O cover gap review in Ireland asks a narrower question than the generic version of this work: not whether directors and officers liability cover exists, but whether the policy a foreign parent bought abroad actually responds to the exposure an Irish board carries under Irish company law. For a cross-border group, the answer usually depends on where the Irish entity's directors are resident, what the Companies Registration Office holds on file about them, and whether the beneficial ownership entered on the Irish register matches what the group believes it disclosed. Ireland's company law creates specific triggers – director residency, register visibility, restriction and disqualification exposure – that a policy drafted for a different jurisdiction rarely anticipates.

A UK or US parent sets up an Irish trading or holding subsidiary, appoints two group executives as directors, and assumes the existing global D&O programme extends to them without adjustment. It usually does, in outline. What it frequently misses is the specific exposure Irish company law attaches to the board seat itself, exposure that has nothing to do with where the parent's insurer happens to be based.

This page sets out what the review has to establish once the company sits in Ireland, where that exposure becomes visible to a regulator or the public register, and where the boundary of this firm's advisory role sits.

What changes in Ireland

Ireland's company law sits in the Companies Act 2014, and it applies the same way to an Irish subsidiary of a multinational as to a wholly domestic company – there is no lighter regime for a foreign-owned entity. The generic D&O cover gap review asks whether the policy responds to the duties a director owes in general terms: care, skill, loyalty, and the statutory duties codified for Irish companies. What changes in Ireland is the layer underneath those duties: a registered office that must be maintained in the state, a regulatory filing schedule the Companies Registration Office enforces, and a residency condition attached to the board itself. A policy underwritten against the general duties, without anyone checking whether the residency condition is actually met, leaves a gap that only becomes visible once something has already gone wrong. Irish company law requires that at least one director of the company is resident in a state within the European Economic Area, unless the company holds a bond of the kind the legislation permits as an alternative. 01

For a cross-border group that staffs its Irish board entirely with directors based abroad, that single condition is very often the first thing the review has to confirm, before anyone asks what the insurance actually covers. Where disagreement over board appointments escalates into deadlock, board deadlock strategy for Irish companies addresses the point at which that disagreement becomes a legal impasse rather than a governance question. A comparable review carried out for the same work in Luxembourg starts from a different constitutional base entirely, which is why this review cannot simply be repeated jurisdiction by jurisdiction from a template.

The local requirement or test that drives the D&O cover gap review in Ireland

The test that drives this work in Ireland is not a licensing test on the director personally. Acting as a director of an Irish company, including for a group other than one's own, is not itself a licensed activity under Irish law; the control mechanism is not a licence but the restriction and disqualification regime the Companies Act applies after the fact. 02 That distinction matters for a D&O cover gap review, because it means the exposure a policy has to answer is not "does this person hold the right licence" but "has this person accepted directors' duties and personal liability that the policy was never underwritten to cover".

Once a director based abroad is put on an Irish board without anyone testing the EEA-residency condition against the actual facts, the gap sits quietly on the company's file. It surfaces only when a filing, an inspection or a dispute forces it into the open. Correcting a residency condition after the fact is far harder than confirming it before the appointment is registered. Once that gap becomes visible to the Companies Registration Office, it cannot be withdrawn from the record. It can only be cured going forward, and the period during which it existed remains part of the company's history.

The checklist a board should be working from before it relies on an existing policy:

• Confirm which director, if any, satisfies the EEA-residency condition, and whether a bond is in place as the alternative.
• Match the company's registered office address held by the Companies Registration Office against the address the group's insurer was told.
• Check whether any director, or the company itself, is subject to a restriction or disqualification order a register search would reveal.
• Confirm the beneficial ownership entered on the register matches the group's own understanding of ownership.
• Ask the insurer, in writing, whether the policy responds to a claim brought in an Irish forum, not only in the parent's home jurisdiction.

A group carrying Irish-registered subsidiaries alongside exposure in other jurisdictions should also read this against how personal liability for unpaid company taxes is tested elsewhere, since the two exposures are frequently reviewed together and rarely covered by the same clause. A director appointed to sit on the board but who never actually attends, votes or receives papers is treated in Ireland the same as one who does. The duties attach to the office, not to the level of participation, which is precisely the assumption a D&O cover gap review has to test rather than accept.

The filing, register or forum consequence

Two Irish registers carry the consequence of getting this wrong, and both are public. The Companies Registration Office maintains the register of directors and secretaries, and it publishes any restriction or disqualification order made against a director, searchable by name. 03 The Central Register of Beneficial Ownership records the beneficial owners of Irish companies and is searchable by members of the public, subject to a limited set of restrictions on the personal data displayed. 04

Once a company's annual return is filed without the director-residency confirmation properly completed, that omission becomes visible on the public file the next time the return is inspected. It cannot be reversed. It can only be corrected by a further regulatory filing that itself becomes part of the permanent record the Companies Registration Office holds. A group that discovers the gap after a claim has already been notified to the insurer is in a materially worse position than one that discovers it during a routine review, because an insurer that later finds the underlying appointment was irregular has grounds to question whether the policy responds at all.

The forum point is separate from the register point, and it is the one cross-border groups miss most often. A claim against an Irish director is ordinarily brought before the Irish courts, applying Irish law, regardless of where the parent company sits or where the global policy was placed. A step-by-step account of how this review is actually run sets out the sequence a board should follow once the register checks are done: confirming forum, confirming the policy's own choice-of-law clause, and confirming that the two are not silently in conflict.

Assess your director exposure against what the two registers actually show, not against what the appointment letter assumed. A board that relies on an insurance certificate without checking the register underneath it is relying on a document the register can contradict without warning. Assess your director exposure. Write to info@hreithlaw.com with the jurisdiction and the structure.

What this service does not include in Ireland

This review does not include acting as, supplying, sourcing or arranging a director, a secretary, a nominee shareholder or a trustee for an Irish company, and it does not include any activity for which a trust or corporate service provider licence would be required. That boundary is not a matter of preference. Providing those functions for a fee, or arranging for someone else to provide them, sits inside a licensing perimeter this firm does not hold and will not act as though it holds.

What the engagement produces instead is analysis the board can act on directly under Irish company law: the residency and register position mapped against the group's actual board composition, the gap between the existing D&O policy and the Irish-specific exposure identified in writing, and an assessment of where personal liability sits once the register checks are complete. The appointment itself, and any person filling it, remains a decision for the board and, where the group chooses to use one, a separately licensed provider.

• A written mapping of the EEA-residency condition against the current board.
• A comparison of the existing D&O policy wording against the Irish forum and register exposure.
• A short memorandum setting out where personal liability sits for each director once the gaps are identified.

A holding structure that discovers a residency gap only after an insurer has already declined a claim faces two problems at once. Only one of them, the policy dispute, is still open to negotiation once the register entry itself is fixed. Assess your director exposure before the next renewal, not after a claim has already been notified. Assess your director exposure. Write to info@hreithlaw.com with the jurisdiction and the structure.

Frequently asked questions

What evidence should the board keep on a D&O cover gap review in Ireland?

Keep the written comparison between the policy wording and the Irish-specific exposure, the register searches carried out at the time, and confirmation of which director satisfied the residency condition. A policy certificate on its own is not evidence that the underlying appointment was in order.

What happens if the D&O cover gap review in Ireland is not addressed?

The exposure does not disappear for being unreviewed. It surfaces at the least convenient moment, usually when a claim is notified and the insurer asks questions the board cannot answer from memory, by which point the register entries are already fixed and can only be corrected going forward.

How often should a D&O cover gap review in Ireland be repeated?

At minimum, whenever the board composition changes, whenever the group restructures its holding of the Irish entity, and at each policy renewal. A residency condition satisfied at incorporation can stop being satisfied years later without anyone noticing.

Does the position change for a foreign-owned company?

No separate regime applies to a foreign-owned Irish company; the same residency condition, the same register obligations and the same forum rule apply regardless of who holds the shares. What changes in practice is that a foreign-owned board is more likely to be staffed entirely by directors resident abroad, which is exactly the fact pattern the residency condition is designed to catch.

What does this work require in practice?

It requires the current board list, the existing D&O policy wording, and access to the company's entries at the Companies Registration Office and the beneficial ownership register. Most of the review is comparing what those three sources actually say against each other, not producing new documents from scratch.

Fiona Marsh, expert author, advises on board governance and director liability across common-law and civil-law jurisdictions, with a focus on the point where a group's global D&O programme meets a local company law regime. Her work concentrates on mapping director exposure before it is tested by a claim, rather than after. She writes on the structural questions that determine whether existing cover actually responds, not on the underwriting of the cover itself.